Literature DB >> 22817619

A decade of cell therapy clinical trials (2000-2010).

Emily J Culme-Seymour1, Natasha L Davie, David A Brindley, Simon Edwards-Parton, Chris Mason.   

Abstract

Mesh:

Year:  2012        PMID: 22817619     DOI: 10.2217/rme.12.45

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


× No keyword cloud information.
  18 in total

1.  Use of data from registered clinical trials to identify gaps in health research and development.

Authors:  Roderik F Viergever; Robert F Terry; Ghassan Karam
Journal:  Bull World Health Organ       Date:  2013-04-03       Impact factor: 9.408

Review 2.  Regenerative medicine: transforming the drug discovery and development paradigm.

Authors:  Sotirios K Karathanasis
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

3.  Regenerative medicinal chemistry: the in situ control of stem cells.

Authors:  Angela J Russell
Journal:  ACS Med Chem Lett       Date:  2013-03-27       Impact factor: 4.345

Review 4.  Biomanufacturing for clinically advanced cell therapies.

Authors:  Ayesha Aijaz; Matthew Li; David Smith; Danika Khong; Courtney LeBlon; Owen S Fenton; Ronke M Olabisi; Steven Libutti; Jay Tischfield; Marcela V Maus; Robert Deans; Rita N Barcia; Daniel G Anderson; Jerome Ritz; Robert Preti; Biju Parekkadan
Journal:  Nat Biomed Eng       Date:  2018-06-11       Impact factor: 25.671

Review 5.  Cell therapy in chronic liver disease.

Authors:  Clara T Nicolas; Yujia Wang; Scott L Nyberg
Journal:  Curr Opin Gastroenterol       Date:  2016-05       Impact factor: 3.287

6.  Photocrosslinked ultrathin anionic polysaccharide supports for accelerated growth of human mesenchymal stem cells.

Authors:  A Mikulska; J Filipowska; A M Osyczka; M Szuwarzyński; M Nowakowska; K Szczubiałka
Journal:  Cell Prolif       Date:  2014-06-25       Impact factor: 6.831

7.  Cell-based therapeutics: the next pillar of medicine.

Authors:  Michael A Fischbach; Jeffrey A Bluestone; Wendell A Lim
Journal:  Sci Transl Med       Date:  2013-04-03       Impact factor: 17.956

8.  Lentivirus Manufacturing Process for Primary T-Cell Biofactory Production.

Authors:  Harikrishnan Radhakrishnan; Harold S Javitz; Parijat Bhatnagar
Journal:  Adv Biosyst       Date:  2020-05-10

9.  Regulation of T cell proliferation with drug-responsive microRNA switches.

Authors:  Remus S Wong; Yvonne Y Chen; Christina D Smolke
Journal:  Nucleic Acids Res       Date:  2018-02-16       Impact factor: 16.971

Review 10.  Nanoparticles and clinically applicable cell tracking.

Authors:  Monique R Bernsen; Jamal Guenoun; Sandra T van Tiel; Gabriel P Krestin
Journal:  Br J Radiol       Date:  2015-08-07       Impact factor: 3.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.